US

MRNA | Moderna

128.60 -3.46 (-2.62%)

MRNA Price Profile

Open

$130.54

CLOSE

$128.60

DAY RANGE

127.66 - 133.00

52 WEEK RANGE

119.01 - 497.49

MARKET CAP

62.83B

Trading volume

0

Prev. Close

132.06

50 Day MA

250.43

Shares Outstanding

405.45M

Public Float

367.58M

Average Volume

10.55M

Beta

1.21

PEG Ratio

0.38

Shares Shorted

16.69M

% OF SHARES SHORTED

5.61%

Short Ratio

1.41

1 Year Performance

-2.05%

Diluted EPS (TTM)

16.69

Q Revenue Growth

30.65

Ebitda

7.77B

Gross Profit (TTM)

-574,877,000

Total Cash (MRQ)

8.91B

Total Debt (MRQ)

583M

  • MRQ = Most Recent Quarter.
  • TTM = Trailing Twelve Months.

Moderna (MRNA) company profile

Moderna Inc. (NASDAQ: MRNA) is a biotechnology company that develops therapeutics and vaccines. The products are based on messenger RNA targetting the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases.

AD